PSYCHEMEDICS CORPORATION (NASDAQ:PMD) Files An 8-K Submission of Matters to a Vote of Security Holders
ITEM 5.07
| SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS |
On May 4, 2017. Psychemedics Corporation (the Company) held its
Annual Meeting of Stockholders. The final results for each of the
matters submitted to a vote of stockholders at the meeting are
set forth below. A more detailed description of each proposal is
set forth in the Companys definitive proxy statement on Form DEF
14A, filed with the U.S. Securities and Exchange Commission on
March 30, 2017 (the Proxy Statement).
Proposal No. 1. Election of Directors. The
stockholders elected five directors to serve until the Companys
2018 Annual Meeting of Stockholders and until their respective
successors are duly elected and qualified, by the votes set forth
in the table below:
| Nominees | For | Withheld | Broker Non-Votes | |||||||||
| Raymond C. Kubacki | 2,989,578 | 7,242 | 1,858,962 | |||||||||
| A. Clinton Allen | 2,893,227 | 12,593 | 1,858,962 | |||||||||
| Harry Connick | 2,882,750 | 23,070 | 1,858,962 | |||||||||
| Walter S. Tomenson, Jr. | 2,892,423 | 13,397 | 1,858,962 | |||||||||
| Fred J. Weinert | 2,892,757 | 13,063 | 1,858,962 | |||||||||
Proposal No. 2. Advisory Vote on Executive
Compensation. The stockholders approved a non-binding
advisory resolution to approve executive compensation, as
described in the Proxy Statement, by the votes set forth in the
table below:
| For | Against | Abstain | Broker Non-Votes | |||
| 2,690,699 | 199,089 | 16,032 | 1,858,962 |
Proposal No. 3. Ratification of Appointment of
Independent Registered Public Accounting Firm. The
stockholders ratified the appointment of BDO USA, LLP as the
Companys independent registered public accounting firm for the
year ending December 31, 2017, by the votes set forth in the
table below:
| For | Against | Abstain | Broker Non-Votes | |||
| 4,750,093 | 7,954 | 6,735 |
About PSYCHEMEDICS CORPORATION (NASDAQ:PMD)
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company’s drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company’s primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company’s tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time. PSYCHEMEDICS CORPORATION (NASDAQ:PMD) Recent Trading Information
PSYCHEMEDICS CORPORATION (NASDAQ:PMD) closed its last trading session up +0.85 at 19.72 with 12,377 shares trading hands.
